Gregg Lucksinger, MD

Medical Director, Principal Investigator
Gregg Lucksinger, MD became interested in clinical research during a 1989 medical school rotation on the NIH schizophrenia research unit in Bethesda, Maryland. Ten years later, he co-founded a clinical research site next to his Family Medicine clinic, conducting high-volume Phase 2-3 clinical trials. Since then, Dr. Lucksinger has served as Principal Investigator on over 200 Phase 1-3 clinical trials in a variety of primary care indications in both inpatient and outpatient settings. He has a special interest in vaccine trials. Dr. Lucksinger joined the team at Velocity Clinical Research in 2020 and currently is the Medical Director of the Cedar Park, Texas location.

Gregg Lucksinger, MD practices at